Valproic acid inhibits cell proliferation and PD-L۱ mediated tumor immune escape throughtargeting CIP۲A and c-MYC/PI۳K/Akt/mTOR signalling molecules in breast cancer
Publish place: 15th International Congress of Breast Cancer
Publish Year: 1400
نوع سند: مقاله کنفرانسی
زبان: English
View: 244
نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد
- Certificate
- من نویسنده این مقاله هستم
این Paper در بخشهای موضوعی زیر دسته بندی شده است:
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
ICBCMED15_002
تاریخ نمایه سازی: 28 شهریور 1401
Abstract:
Resistant cells are a critical problem that reducetreatment efficacy of breast cancer. Nowadays,CIP۲A and PD-L۱ are considered as theraputicalchallenges in breast cancer, because ofresponsible for drug resistance and immuneevasion respectively. Hence, identifying agents tosuppress these factors is great of interest.Specifically, epigenetic drugs can be an effectiveapproach to alter the behavior of genes. Althoughvalproic acid (VPA) as a HDAC inhibitor hascertain anticancer properties but molecularmechanism of VPA in breast cancer cells remainsto be explored. In this study, we investigated drugeffects and molecular mechanisms of VPA,particularly its effect on CIP۲A and PD-L۱ inbreast cancer MCF-۷ cell line.In this study, MCF-۷ cells were treated withvarious concentration of VPA for ۲۴ h, ۴۸ h, and۷۲ h. The rate of cell viability was measured byMTT assay. Finally, gene expressions of CIP۲A,c-MYC, PI۳K, Akt, mTOR and PD-L۱ wereanalyzed by real time PCR and ΔCT method.
Keywords:
Authors
Elahe Zeinali
Department of Immunology and Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran
Vahid Bagheri
Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran
Esmaeil Rostami
Department of Laboratory Sciences, Faculty of Para- Medicine, Sabzevar University of Medical Sciences, Sabzevar, Iran
Gholamreza Anani Sarab
Cellular & Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran.